483
Stanford Blood CenterFDA 483 - Stanford Blood Center - June 16, 2010
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Stanford Medical School Blood Center in Palo Alto, CA, a blood bank. The inspection revealed significant issues related to the investigation of adverse reactions, specifically regarding a donor deferral. Additionally, the firm failed to submit multiple biological product deviation reports within the required timeframe.
Open in Dashboard
ID · 9018f4b0-531f-4439-b5d6-3d0314a4d6ec